Compare Hewlett Packard Enterprise Co (HPE) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hewlett Packard Enterprise Co vs Natera Inc. Common Stock — how do they compare? Hewlett Packard Enterprise Co trades at $61.49 (market cap $91.34B), while Natera Inc. Common Stock trades at $394 (market cap $57.03B). The key difference: Hewlett Packard Enterprise Co is the larger of the two by market cap, and Hewlett Packard Enterprise Co pays a 0.83% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hewlett Packard Enterprise Co for 34 Days and Natera Inc. Common Stock for 0 Days on average.
| HPE | NTRA | |
|---|---|---|
Market Cap | $91.34B | $57.03B |
Volume | 23,977,697 | 1,131,157 |
Sector | Technology | Health |
52-Week High | $73.46 | $425.64 |
52-Week Low | $20.01 | $179.42 |
Typical Hold Time | 34 Days | 0 Days |
Enterprise Value | $105.37B | $56.18B |
Dividend Yield | 0.83% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HPE stock trades at $63.17, down 10.14% today but remains near recent highs following strong AI infrastructure demand. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 EPS of $1.11 exceeding expectations by 19%. Technical indicators show a bullish trend with support at $66 and resistance at $72. Recent news highlights a $1.2 billion AI server order from Vultr and upgraded guidance, driving positive sentiment.
HPE presents growth potential from AI infrastructure expansion and strong earnings momentum, though valuation appears elevated with a P/E of 35.47. Key risks include execution challenges in integrating Juniper Networks and competitive pressures in the server market. Analyst consensus targets $70.00 with 47.5% buy ratings, suggesting moderate upside from current levels.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hewlett Packard Enterprise Co
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment.
Read more on HPE →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
